138 related articles for article (PubMed ID: 31734399)
21. [Reliability and clinical utility of Enzyme-linked immunosorbent assay for detection of anti-aminoacyl-tRNA synthetase antibody].
Abe T; Tsunoda S; Nishioka A; Azuma K; Tsuboi K; Ogita C; Yokoyama Y; Furukawa T; Maruoka M; Tamura M; Yoshikawa T; Saito A; Sekiguchi M; Azuma N; Kitano M; Matsui K; Hosono Y; Nakashima R; Ohmura K; Mimori T; Sano H
Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(2):140-4. PubMed ID: 27212600
[TBL] [Abstract][Full Text] [Related]
22. Anti-PM/Scl antibody-positive dermatomyositis in a Japanese patient: a case report and review of the literature.
Kohara A; Yanaba K; Muro Y; Ito H; Nakagawa H; Noda K; Kurosaka D
Int J Rheum Dis; 2017 Dec; 20(12):2186-2189. PubMed ID: 28185425
[No Abstract] [Full Text] [Related]
23. [Dermatomyositis associated with anti-MDA5 autoantibody].
Collado MV; Gargiulo MLÁ; Gómez R; Gómez G; Pérez N; Suarez L; Taratuto AL; Aruj P
Medicina (B Aires); 2018; 78(5):360-363. PubMed ID: 30285929
[TBL] [Abstract][Full Text] [Related]
24. Autoantibody Specificities and Type I Interferon Pathway Activation in Idiopathic Inflammatory Myopathies.
Ekholm L; Vosslamber S; Tjärnlund A; de Jong TD; Betteridge Z; McHugh N; Plestilova L; Klein M; Padyukov L; Voskuyl AE; Bultink IE; Michiel Pegtel D; Mavragani CP; Crow MK; Vencovsky J; Lundberg IE; Verweij CL
Scand J Immunol; 2016 Aug; 84(2):100-9. PubMed ID: 27173897
[TBL] [Abstract][Full Text] [Related]
25. Anti-MDA5 antibody as a potential diagnostic and prognostic biomarker in patients with dermatomyositis.
Li L; Wang Q; Yang F; Wu C; Chen S; Wen X; Liu C; Li Y
Oncotarget; 2017 Apr; 8(16):26552-26564. PubMed ID: 28460448
[TBL] [Abstract][Full Text] [Related]
26. Four dermatomyositis-specific autoantibodies-anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort.
Bodoki L; Nagy-Vincze M; Griger Z; Betteridge Z; Szöllősi L; Dankó K
Autoimmun Rev; 2014 Dec; 13(12):1211-9. PubMed ID: 25182203
[TBL] [Abstract][Full Text] [Related]
27. Clinical features of anti-TIF1-α antibody-positive dermatomyositis patients are closely associated with coexistent dermatomyositis-specific autoantibodies and anti-TIF1-γ or anti-Mi-2 autoantibodies.
Muro Y; Ishikawa A; Sugiura K; Akiyama M
Rheumatology (Oxford); 2012 Aug; 51(8):1508-13. PubMed ID: 22539482
[TBL] [Abstract][Full Text] [Related]
28. Association of distinct clinical subsets with myositis-specific autoantibodies towards anti-155/140-kDa polypeptides, anti-140-kDa polypeptides, and anti-aminoacyl tRNA synthetases in Japanese patients with dermatomyositis: a single-centre, cross-sectional study.
Fujikawa K; Kawakami A; Kaji K; Fujimoto M; Kawashiri S; Iwamoto N; Aramaki T; Ichinose K; Tamai M; Kamachi M; Nakamura H; Ida H; Origuchi T; Ishimoto H; Mukae H; Kuwana M; Kohno S; Takehara K; Sato S; Eguchi K
Scand J Rheumatol; 2009; 38(4):263-7. PubMed ID: 19444719
[TBL] [Abstract][Full Text] [Related]
29. Clinical and biochemical characteristics of autoantibody systems in polymyositis and dermatomyositis.
Fudman EJ; Schnitzer TJ
Semin Arthritis Rheum; 1986 May; 15(4):255-60. PubMed ID: 3520822
[No Abstract] [Full Text] [Related]
30. [Myositis-specific antibodies associated with juvenile dermatomyositis].
Eising K; Peitz J; Unterwalder N; Meisel C; Horneff G
Z Rheumatol; 2018 Oct; 77(8):735-740. PubMed ID: 29411095
[TBL] [Abstract][Full Text] [Related]
31. Low prevalence of anti-small ubiquitin-like modifier activating enzyme antibodies in dermatomyositis patients.
Muro Y; Sugiura K; Akiyama M
Autoimmunity; 2013 Jun; 46(4):279-84. PubMed ID: 23215730
[TBL] [Abstract][Full Text] [Related]
32. Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies.
Hengstman GJ; Brouwer R; Egberts WT; Seelig HP; Jongen PJ; van Venrooij WJ; van Engelen BG
J Neurol; 2002 Jan; 249(1):69-75. PubMed ID: 11954871
[TBL] [Abstract][Full Text] [Related]
33. Use of Anti-transcriptional Intermediary Factor-1 Gamma Autoantibody in Identifying Adult Dermatomyositis Patients with Cancer: A Systematic Review and Meta-analysis.
Best M; Molinari N; Chasset F; Vincent T; Cordel N; Bessis D
Acta Derm Venereol; 2019 Mar; 99(3):256-262. PubMed ID: 30460368
[TBL] [Abstract][Full Text] [Related]
34. Anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase autoantibody-positive necrotizing autoimmune myopathy with dermatomyositis-like eruption.
Parikh P; Tavee J; Soltanzadeh P; Mammen AL; McKeever P; Li Y
Muscle Nerve; 2018 Jun; 57(6):E135-E136. PubMed ID: 29346706
[No Abstract] [Full Text] [Related]
35. Autoantibodies in children with juvenile dermatomyositis: A single centre experience from North-West India.
Hussain A; Rawat A; Jindal AK; Gupta A; Singh S
Rheumatol Int; 2017 May; 37(5):807-812. PubMed ID: 28331982
[TBL] [Abstract][Full Text] [Related]
36. Clinical Utility of an Enzyme-Linked Immunosorbent Assay for Detecting Anti-Melanoma Differentiation-Associated Gene 5 Autoantibodies.
Sato S; Murakami A; Kuwajima A; Takehara K; Mimori T; Kawakami A; Mishima M; Suda T; Seishima M; Fujimoto M; Kuwana M
PLoS One; 2016; 11(4):e0154285. PubMed ID: 27115353
[TBL] [Abstract][Full Text] [Related]
37. Recent advances in dermatomyositis-specific autoantibodies.
Fujimoto M; Watanabe R; Ishitsuka Y; Okiyama N
Curr Opin Rheumatol; 2016 Nov; 28(6):636-44. PubMed ID: 27533321
[TBL] [Abstract][Full Text] [Related]
38. An enzyme-linked immunosorbent assay for the detection and quantitation of anti-Jo-1 antibody in human serum.
Biswas T; Miller FW; Takagaki Y; Plotz PH
J Immunol Methods; 1987 Apr; 98(2):243-8. PubMed ID: 3494784
[TBL] [Abstract][Full Text] [Related]
39. Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies.
Yamaguchi K; Yamaguchi A; Kashiwagi C; Sawada Y; Taguchi K; Umetsu K; Oshima K; Uchida M; Suzuki M; Kono S; Takemura M; Masubuchi H; Kitahara S; Hara K; Maeno T; Motegi SI; Muro Y; Sakairi T; Hisada T; Kurabayashi M
Respir Med; 2018 Jul; 140():1-5. PubMed ID: 29957268
[TBL] [Abstract][Full Text] [Related]
40. Frequency and clinical relevance of anti-Mi-2 autoantibody in adult Brazilian patients with dermatomyositis.
Dos Passos Carvalho MIC; Shinjo SK
Adv Rheumatol; 2019 Jul; 59(1):27. PubMed ID: 31266544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
